Navigation Links
Kendle Expands Global Clinical Pharmacology Capabilities with Acquisition of DecisionLine Clinical Research Corporation
Date:6/2/2008

DecisionLine adds high-end exploratory/translational medicine capabilities and world-leading scientific psychopharmacology expertise; supports Kendle

strategic initiative to drive growth in its early phase business

CINCINNATI, June 2 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading global full-service clinical research organization (CRO), today announced the acquisition of DecisionLine Clinical Research Corporation (DecisionLine Clinical Services), a privately owned, early phase CRO with a state-of-the-art medical facility in Toronto, Canada. DecisionLine specializes in the conduct of Phase I studies involving the measurement of pharmacodynamic effects of central nervous system (CNS) drugs, and is recognized worldwide as a leader in the conduct of human abuse liability studies and the assessment of abuse potential and risk mitigation. The company brings to Kendle extensive world-class scientific expertise with psychopharmacology high-end exploratory/translational medicine capabilities, from first-in-human to proof-of-concept trial conduct, as well as drug development consulting, medical writing, data management, biostatistics and other support services. Kendle acquired DecisionLine for an undisclosed cash amount. Specific terms of the transaction were not disclosed. The acquired business will report into Philip J.W. Davies, Vice President, Early Phase.

(Logo: http://www.newscom.com/cgi-bin/prnh/20030429/KNDLLOGO )

"With Phase I growth expected to outpace the broader outsourcing market at approximately 15 percent annually, early phase development remains an important need for our customers and an area of significant growth
'/>"/>

SOURCE Kendle International Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Kendle to Ring Opening Bell at NASDAQ Stock Market on August 22
2. Kendle Marks 10th Anniversary as Public Company With NASDAQ Opening Bell Ceremony and Investor Day Event
3. Kendle to Present at Thomas Weisel Partners Healthcare Conference 2007
4. Kendle to Present at Bear Stearns 20th Annual Healthcare Conference
5. Kendle to Present at the UBS Global Life Sciences Conference
6. Kendle to Present at the Natixis Bleichroeder Hidden Gems Conference
7. Kendle Invites You to Attend Its Third Quarter 2007 Earnings Conference Call and Webcast
8. Kendle Named Best CRO for Second Consecutive Year by Leading Global Pharmaceutical Publication Scrip
9. Kendle Appoints Former MHRA Head of Biologics as Principal Regulatory Affairs Consultant
10. Kendle to Present at the Wachovia 2008 Healthcare Conference
11. Kendle Hires Satish Tripathi, PhD, RAC as Vice President, Global Regulatory and Quality
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... July 30, 2015 AACC welcomed thousands ... 2015 AACC Annual Meeting & Clinical Lab Expo ... 26–30. The meeting showcased revolutionary advancements in clinical ... of healthcare providers to diagnose patients quickly and ... treatment. As of Wednesday, July ...
(Date:7/30/2015)... ... July 30, 2015 , ... Tronics, a designer ... & Marketing Director. , With more than 25 years of experience in ... Tronics’ business development activities worldwide. He brings to the company his strong expertise ...
(Date:7/30/2015)... 30, 2015 According to a ... Molecular Modeling, PB/PK, PKPD, Trial Design, Toxicity Prediction, In-house, ... Clinical Trial), by End Users - Global Forecast to ... to reach USD 2,107.99 million by 2020 from USD ... Browse more than 75 ...
(Date:7/30/2015)... , July 30, 2015   Aratana Therapeutics, ... therapeutics company focused on the licensing, development and ... today announced that its strategic partner VetStem Biopharma, ... confirmation study of AT-016, an adipose-derived allogeneic stem ... treatment of osteoarthritis pain in dogs. ...
Breaking Biology Technology:Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 2Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 3Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 4Tronics appoints Francois Vieillard as Sales and Marketing Director 2Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 5
... across your field of vision is a step closer to ... could potentially provide the wearer with hands-free information updates. ... Publishing,s Journal of Micromechanics and Microengineering , researchers constructed ... it on live eyes. There were no signs of adverse ...
... of Scientific Research (AFOSR) was chosen by Time Magazine for its ... Aliev, Yuri Gartstein and Ray Baughman, of the University of Texas ... to as the "mirage effect from thermally modulated transparent carbon nanotube ... an ,invisibility cloak,." The key to ...
...  According to results from the most recent McGladrey ... those in the durable goods sector, suffered from a ... energy and raw materials costs, and falling business and ... Monitor participants say their businesses are thriving and growing. ...
Cached Biology Technology:Terminator-style info-vision takes step towards reality 2McGladrey Manufacturing and Distribution Monitor® Shows Business Accelerating Despite Concerns About Government Gridlock 2McGladrey Manufacturing and Distribution Monitor® Shows Business Accelerating Despite Concerns About Government Gridlock 3McGladrey Manufacturing and Distribution Monitor® Shows Business Accelerating Despite Concerns About Government Gridlock 4
(Date:7/31/2015)... , 31. Juli 2015 Die 10. internationale ... von BGI veranstaltet und findet vom 22. bis ... , statt. Die Konferenz ... ihrem Start 2006 ist die ICG weltweit zu ... geworden. Sie ist eines der dynamischsten, enthusiastischsten und ...
(Date:7/31/2015)... , July 31, 2015 The 10 th ... be held by BGI from October 22-25, 2015, in ... The conference is celebrating its 10 th anniversary this ... of the world,s most influential annual meetings in the ,omics, ... enjoyable scientific gatherings. ICG-10 focuses on recent ...
(Date:7/27/2015)... JOSE, Calif. , July 27, 2015 /PRNewswire/ ... developer of human interface solutions, today announced that ... ® touchscreen solution for its stylish smartwatch. ... for its proven reliability, low power and highly ... a wet finger. Huawei designers also required a ...
Breaking Biology News(10 mins):Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 2Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 3The 10th International Conference on Genomics (ICG-10) to Open in October 2Synaptics Touchscreen Solution Powers New Huawei Watch 2Synaptics Touchscreen Solution Powers New Huawei Watch 3
... Inspired by recent breakthroughs in research, today the International ... entitled Research to Reality: Funding Progress. Funds raised ... of crucial research, and bring promise to reality. ... her battle with Rett syndrome in 2003 at age ...
... The Laboratory for Virology and Experimental Chemotherapy (Rega Institute) ... K.U.Leuven will receive a total of 2.8 million euro from ... the search for possible new medication for the treatment of ... fever, is widespread in tropical and subtropical regions. As of ...
... of researchers led by geneticist Jonathan Sebat, Ph.D., of Cold ... chromosome 16 that substantially increases risk for schizophrenia. ... number variant (CNV). CNVs are areas of the genome where ... CNV is located in a region referred to by scientists ...
Cached Biology News:IRSF receives $1 million matching gift 2IRSF receives $1 million matching gift 3Wellcome Trust funds dengue fever research in Leuven 2CSHL-led team discovers rare mutation dramatically increasing schizophrenia risk 2